Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Carlos R. K. Paier"'
Autor:
Arlindo A. Moura, Maria Julia B. Bezerra, Aline M. A. Martins, Daniela P. Borges, Roberta T. G. Oliveira, Raphaela M. Oliveira, Kaio M. Farias, Arabela G. Viana, Guilherme G. C. Carvalho, Carlos R. K. Paier, Marcelo V. Sousa, Wagner Fontes, Carlos A. O. Ricart, Maria Elisabete A. Moraes, Silvia M. M. Magalhães, Cristiana L. M. Furtado, Manoel O. Moraes-Filho, Claudia Pessoa, Ronald F. Pinheiro
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Myelodysplastic syndrome (MDS) is a hematological disorder characterized by abnormal stem cell differentiation and a high risk of acute myeloid leukemia transformation. Treatment options for MDS are still limited, making the identification of molecul
Externí odkaz:
https://doaj.org/article/dda80638a65f48de9781d4b7321b8246
Autor:
Letícia B. C. Penariol, Carolina H. Thomé, Patrícia A. Tozetti, Carlos R. K. Paier, Fabiana O. Buono, Kamila C. Peronni, Maristela D. Orellana, Dimas T. Covas, Maria E. A. Moraes, Wilson A. Silva, Júlio C. Rosa-e-Silva, Rui A. Ferriani, Vitor M. Faça, Omero B. Poli-Neto, Daniel G. Tiezzi, Juliana Meola
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 19, p 11515 (2022)
Given the importance of menstrual blood in the pathogenesis of endometriosis and the multifunctional roles of menstrual mesenchymal stem cells (MenSCs) in regenerative medicine, this issue has gained prominence in the scientific community. Moreover,
Externí odkaz:
https://doaj.org/article/adf3e98a055f42dca3b7d64424a1f8bd
Autor:
Arlindo A. Moura, Maria Julia B. Bezerra, Aline M. A. Martins, Daniela P. Borges, Roberta T. G. Oliveira, Raphaela M. Oliveira, Kaio M. Farias, Arabela G. Viana, Guilherme G. C. Carvalho, Carlos R. K. Paier, Marcelo V. Sousa, Wagner Fontes, Carlos A. O. Ricart, Maria Elisabete A. Moraes, Silvia M. M. Magalhães, Cristiana L. M. Furtado, Manoel O. Moraes-Filho, Claudia Pessoa, Ronald F. Pinheiro
Publikováno v:
Frontiers in oncology. 12
Myelodysplastic syndrome (MDS) is a hematological disorder characterized by abnormal stem cell differentiation and a high risk of acute myeloid leukemia transformation. Treatment options for MDS are still limited, making the identification of molecul